A Slovenian company that makes an antioxidant pill some media have dubbed an “elixir of youth” is threatening to file lawsuits against scientists who have publicly spoken out against the product, calling it insufficiently tested. The face-off has an added bit of complexity: one prominent Croatian scientist is criticising another who has endorsed the therapy.
Full article in ScienceInsider
Mićo Tatalović
Science journalist at New Scientist
Mićo Tatalović is environment and life science news editor at New Scientist magazine. He is also the chair of the board of the Association of British Science Writers and is actively involved in promoting science journalism in South-East Europe.
He runs the EuroScientist blog Balkan Science Beat.
He runs the EuroScientist blog Balkan Science Beat.
Latest posts by Mićo Tatalović (see all)
- Trump’s border wall in Europe is already hurting wildlife and – hopefully – our conscience - 20 October, 2016
- What do Croatia’s election results mean for its neglected science? - 14 September, 2016
- Eastern European countries snub neighbours’ science policy - 26 November, 2014
